710010login-checkTransplant May Be Reasonable for Certain CRC Patients With Liver Mets |
— OS rates could be over 80% depending on clinical predictive factors
By Mike Bassett
For a select group of patients with colorectal cancer and unresectable liver metastases, liver transplant may be a reasonable option, according to results from a prospective, nonrandomized controlled cohort study.
Overall, among 61 patients who underwent liver transplant, the median disease-free survival (DFS) was 11.8 months (95% CI 9.3-14.2), with a 5-year DFS rate of 18.3%, and the median overall survival (OS) was 60.3 months (95% CI 44.3-76.4), with a 5-year OS rate of 50.4%, reported Svein Dueland, MD, PhD, of Oslo University Hospital in Norway, and colleagues. Read the full article in MedPage Today.
710010login-checkTransplant May Be Reasonable for Certain CRC Patients With Liver Mets |